Uncovering the Underlying Mechanisms of Ketamine as a Novel Antidepressant.

Xu, Songbai; Yao, Xiaoxiao; Li, Bingjin; Cui, Ranji; Zhu, Cuilin; Wang, Yao; Yang, Wei

Xu, Songbai; Yao, Xiaoxiao; Li, Bingjin; Cui, Ranji; Zhu, Cuilin; Wang, Yao; Yang, Wei.

Afiliação

Xu S; Department of Neurosurgery, First Hospital of Jilin University, Changchun, China.
Yao X; Jilin Provincial Key Laboratory on Molecular and Chemical Genetic, The Second Hospital of Jilin University, Changchun, China.
Li B; Jilin Provincial Key Laboratory on Molecular and Chemical Genetic, The Second Hospital of Jilin University, Changchun, China.
Cui R; Jilin Provincial Key Laboratory on Molecular and Chemical Genetic, The Second Hospital of Jilin University, Changchun, China.
Zhu C; Department of Cardiovascular Surgery, The Second Hospital of Jilin University, Changchun, China.
Wang Y; Jilin Provincial Key Laboratory on Molecular and Chemical Genetic, The Second Hospital of Jilin University, Changchun, China.
Yang W; Jilin Provincial Key Laboratory on Molecular and Chemical Genetic, The Second Hospital of Jilin University, Changchun, China.

Front Pharmacol ; 12: 740996, 2021.

Article em En | MEDLINE | ID: mdl-35872836

Palavras-chave

BDNF; NMDAR; antidepressant; ketamine; mTOR; major depressive disorder

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Front Pharmacol Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google